Found: first rocky exoplanet that could host life
from New Scientist - Online News
(2010-9-30 7:34)
|
A rocky body about three times as massive as Earth has been found in the cosy "habitable zone" around its star– the find suggests habitable planets are common
|
Monkeys bid to join elite self-awareness club
from New Scientist - Online News
(2010-9-30 5:00)
|
Rhesus macaque monkeys have shown they can recognise their own reflection in a mirror, suggesting that, like humans and other apes, they are self-aware
|
Rivers threatened around the world
from New Scientist - Online News
(2010-9-30 2:01)
|
Water security threatens humans and wildlife alike, says a global survey– and technology has only tackled half the problem
|
Today on New Scientist: 29 September 2010
from New Scientist - Online News
(2010-9-30 2:00)
|
All today's stories on newscientist.com, including: the origins of altruism, wild plants facing extinction and the countdown to oblivion
|
Fossil secrets of the da Vinci codex
from New Scientist - Online News
(2010-9-30 2:00)
|
Did Leonardo decipher traces of ancient life centuries before Darwin?
|
Anti-antibiotics: Bugs, drugs and bureaucrats
from New Scientist - Online News
(2010-9-30 1:42)
|
Why are drug regulatory agencies discouraging the development of new antibiotics?
|
Cosmic accidents: Mars attacks
from New Scientist - Online News
(2010-9-30 1:27)
|
A colossal interplanetary collision doesn't sound like a good thing? but without it, things might have turned out very differently
|
The geometric pedestal of string theory
from New Scientist - Online News
(2010-9-30 0:48)
|
In The Shape of Inner Space, Shing-Tung Yau and Steve Nadis fight string theory's corner by explaining multidimensional geometry
|
Sparks fly over origin of altruism
from New Scientist - Online News
(2010-9-29 22:38)
|
A new view of kin selection says it is part of a broader theory describing the evolution of behaviour in general
|
Reports of miracle drugs are no substitute for trials
from New Scientist - Online News
(2010-9-29 22:14)
|
How did a collection of case reports lead to an untested drug being administered all over the world to people with serious bleeding, asks Ian Roberts
|